版本:
中国

BRIEF-Intra-Cellular therapies reports Q1 loss per share $0.62

May 10 Intra-cellular Therapies Inc:

* Intra-Cellular therapies reports first quarter 2017 financial results and provides corporate update

* Q1 loss per share $0.62

* Q1 earnings per share view $-0.72 -- Thomson Reuters I/B/E/S

* research and development (research and development) expenses for Q1 of 2017 were $21.5 million, compared to $23.4 million for Q1 of 2016

* Intra-Cellular Therapies- cash, cash equivalents and investment securities totaled $367.8 million at march 31, 2017, compared to $384.1 million at December 31, 2016

* Qtrly revenues $95,287 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐